Author

Emerald Kan

Baylor College of Medicine

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Assay:spatial transcriptomics· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Approach:deep learning· 1 Approach:experimental assay· 1 Assay:metabolomics· 1

Frequent Co-Authors

Kelli A. McCordiD· 2 shared Sean HyslopiD· 2 shared Vlad Constantin SandulacheiD· 2 shared William Henry HudsoniD· 2 shared Abdullah A. OsmaniD· 1 shared Amanda Y. XiaiD· 1 shared Andreas WielandiD· 1 shared Chandrashekar R. AmbatiiD· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

Kelli A. McCordORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Single-cell, Spatially-Resolved TCR Profiling Links T Cell Phenotype and Clonality in Human Tumors

Kelli A. McCord, Emerald Kan, Sean Hyslop, Amanda Y. Xia, Colby J. Hofferek, James S. Lewis, Andreas Wieland, David J. Hernandez, Vlad Constantin Sandulache, William Henry Hudson

The paper develops a multimodal profiling framework to analyze T cell phenotype and clonality in HNSCC tumors, revealing spatial and antigen-specific differences in T cell function.

Science Immunology · Apr 10, 2026Peer-reviewedImmunology

Bypassing cisplatin resistance in Nrf2 hyperactivated head and neck cancer through effective PI3Kinase targeting

Pedram Yadollahi, Kelli A. McCord, Li Yang, Hussam Dayoub, Kalil Saab, Fonma Essien, Sean Hyslop, Emerald Kan, Kazi Mokim Ahmed, Parker R. Kirby, Vasanta Putluri, Chandrashekar R. Ambati, Karthik Reddy Kami Reddy, Patricia D. Castro, Heath Devin Skinner, , Vlad Constantin Sandulache

This paper identifies PI3K pathway activation in Nrf2-driven cisplatin-resistant HNSCC and shows that gedatolisib inhibits tumor growth and re-sensitizes cells to cisplatin.

British Journal of Cancer · Oct 6, 2025Peer-reviewedCancer Biology